Non-bone metastatic cancers promote osteocyte-induced bone destruction.
Animals
Apoptosis
/ genetics
Bone Neoplasms
/ genetics
Bone and Bones
/ metabolism
Carcinoma, Lewis Lung
/ genetics
Cathepsin K
/ genetics
Colonic Neoplasms
/ genetics
Female
Gene Expression Regulation, Neoplastic
/ genetics
Humans
Matrix Metalloproteinase 13
/ genetics
Mice
Neoplasm Metastasis
Osteoclasts
/ metabolism
Osteocytes
/ metabolism
Osteolysis
/ genetics
Ovarian Neoplasms
/ genetics
Tartrate-Resistant Acid Phosphatase
/ genetics
Vacuolar Proton-Translocating ATPases
/ genetics
Bone resorption
Cancer cachexia
Osteocytes
Osteocytic osteolysis
Journal
Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
received:
20
03
2021
revised:
24
06
2021
accepted:
29
06
2021
pubmed:
8
7
2021
medline:
8
1
2022
entrez:
7
7
2021
Statut:
ppublish
Résumé
The effects of bone metastatic cancer on the skeleton are well described, whereas less is known regarding the effects of non-metastatic bone cancer on bone. Here we investigated the effects of three non-bone metastatic cancer cachexia models, namely Colon-26 adenocarcinoma (C26), ES-2 ovarian cancer (ES-2), and Lewis lung carcinoma (LLC). Even though C26, ES-2 and LLC tumor growth resulted in comparable weight and muscle loss, the ES-2 and LLC hosts exhibited severe bone loss, whereas only modest bone loss was observed in the C26 bearers, correlating with increased TRAP
Identifiants
pubmed: 34233150
pii: S0304-3835(21)00324-4
doi: 10.1016/j.canlet.2021.06.030
pmc: PMC8440379
mid: NIHMS1724025
pii:
doi:
Substances chimiques
Acp5 protein, mouse
EC 3.1.3.2
Tartrate-Resistant Acid Phosphatase
EC 3.1.3.2
Cathepsin K
EC 3.4.22.38
Ctsk protein, mouse
EC 3.4.22.38
Matrix Metalloproteinase 13
EC 3.4.24.-
Mmp13 protein, mouse
EC 3.4.24.-
Atp6v0d2 protein, mouse
EC 3.6.1.-
Vacuolar Proton-Translocating ATPases
EC 3.6.1.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
80-90Subventions
Organisme : NIAMS NIH HHS
ID : P01 AR046798
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR065971
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Références
World J Orthop. 2015 Sep 18;6(8):590-601
pubmed: 26396935
Cancer Res. 2000 Feb 15;60(4):783-7
pubmed: 10706080
Int J Mol Sci. 2021 Feb 02;22(3):
pubmed: 33540821
Cancers (Basel). 2018 Jun 04;10(6):
pubmed: 29867053
Bone. 2013 Jun;54(2):264-71
pubmed: 23238124
Int J Mol Sci. 2016 Dec 06;17(12):
pubmed: 27929439
Ther Adv Musculoskelet Dis. 2009 Apr;1(2):87-96
pubmed: 22870430
J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):685-700
pubmed: 30009406
Curr Osteoporos Rep. 2013 Sep;11(3):163-70
pubmed: 23877475
Front Endocrinol (Lausanne). 2019 May 14;10:285
pubmed: 31139147
Physiol Rep. 2013 Nov;1(6):e00144
pubmed: 24400146
Eur J Endocrinol. 2011 Jul;165(1):1-10
pubmed: 21543379
Leukemia. 2012 Jun;26(6):1391-401
pubmed: 22289923
J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
Nutr Clin Pract. 2017 Feb;32(1):30-39
pubmed: 28124947
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):261-3
pubmed: 25384990
Endocr Rev. 2011 Feb;32(1):31-63
pubmed: 20851921
US Oncol. 2009;5(2):20-23
pubmed: 21853012
J Bone Miner Res. 2017 Aug;32(8):1761-1772
pubmed: 28470757
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1779-1798
pubmed: 33200567
Oncol Nurs Forum. 2009 Mar;36(2):194-202
pubmed: 19273408
J Musculoskelet Neuronal Interact. 2002 Dec;2(6):570-2
pubmed: 15758398
Nat Med. 2015 Nov;21(11):1262-1271
pubmed: 26457758
JCI Insight. 2019 Apr 9;5:
pubmed: 30965315
J Biol Chem. 2014 Mar 21;289(12):8508-20
pubmed: 24509854
Mol Med Rep. 2018 May;17(5):6605-6611
pubmed: 29512766
Annu Rev Physiol. 2020 Feb 10;82:485-506
pubmed: 32040934
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Int J Mol Sci. 2019 Oct 09;20(20):
pubmed: 31600911
J Clin Invest. 2020 Sep 1;130(9):4811-4830
pubmed: 32773408
Cancer Treat Rev. 2010 Dec;36(8):615-20
pubmed: 20478658
Oncotarget. 2015 Dec 22;6(41):43202-15
pubmed: 26636649
Bone Res. 2020 Jul 29;8:30
pubmed: 32793401
Jpn J Clin Oncol. 2002 Oct;32(10):422-4
pubmed: 12451040
Bone. 1992;13(4):327-30
pubmed: 1389573
J Bone Miner Res. 2011 Feb;26(2):229-38
pubmed: 21254230
Exp Oncol. 2018 Jun;40(2):136-139
pubmed: 29949526
J Musculoskelet Neuronal Interact. 2018 Sep 1;18(3):292-303
pubmed: 30179206
Nutr Cancer. 2015;67(7):1056-62
pubmed: 26317149
J Palliat Med. 2013 Aug;16(8):915-21
pubmed: 23819731
J Bone Miner Res. 2020 Feb;35(2):368-381
pubmed: 31614017
Cell Death Dis. 2020 Oct 12;11(10):846
pubmed: 33046704
J Cell Physiol. 2003 Feb;194(2):194-205
pubmed: 12494458
Front Physiol. 2017 Jan 11;7:679
pubmed: 28123369
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
J Bone Miner Res. 2016 Jul;31(7):1356-65
pubmed: 26852281
J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):95-104
pubmed: 21766055
Qual Life Res. 2007 Aug;16(6):947-60
pubmed: 17457697
Front Endocrinol (Lausanne). 2019 Nov 19;10:809
pubmed: 31803146
J Bone Miner Res. 2012 May;27(5):1018-29
pubmed: 22308018
Biochem Biophys Res Commun. 2019 Nov 12;519(3):566-571
pubmed: 31537378
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13361-2
pubmed: 9811806
Nat Rev Cancer. 2011 Jun;11(6):411-25
pubmed: 21593787
J Bone Miner Res. 2011 Nov;26(11):2634-46
pubmed: 21735478
Nat Rev Cancer. 2002 Aug;2(8):584-93
pubmed: 12154351
Br J Cancer. 1999 Mar;79(7-8):1179-81
pubmed: 10098755
Aging Cell. 2017 Jun;16(3):551-563
pubmed: 28317237
Cell Metab. 2016 Feb 9;23(2):315-23
pubmed: 26669699
J Vis Exp. 2016 Nov 30;(117):
pubmed: 27929469